(Q30747776)

26 June 2017

1 reference

title

Discovering novel phenotype-selective neurotrophic factors to treat neurodegenerative diseases (English)

1 reference

26 June 2017

1 reference

1 reference

Penka S Petrova

1 reference

26 June 2017

Andrei Raibekas

1 reference

26 June 2017

Jonathan Pevsner

1 reference

26 June 2017

Noel Vigo

1 reference

26 June 2017

Mordechai Anafi

1 reference

26 June 2017

Mary K Moore

1 reference

26 June 2017

Amy Peaire

1 reference

26 June 2017

Viji Shridhar

1 reference

26 June 2017

David I Smith

1 reference

26 June 2017

John Kelly

1 reference

26 June 2017

Yves Durocher

1 reference

26 June 2017

John W Commissiong

1 reference

26 June 2017

publication date

1 January 2004

1 reference

Progress in Brain Research

26 June 2017

published in

1 reference

26 June 2017

volume

146

1 reference

26 June 2017

page(s)

168-183

1 reference

The GDNF family: signalling, biological functions and therapeutic value

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

BDNF gene transcripts in mesencephalic neurons and its differential regulation by NMDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Dynamic signaling between astrocytes and neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Different signalling pathways involved in transforming growth factor-beta 1-induced morphological change and type IV collagen synthesis in simian virus-40-immortalized normal human salivary gland duct and myoepithelial cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Neurotrophic factors: an evolutionary perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Control of synaptic strength by glial TNFalpha

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Design and solution structure of functional peptide mimetics of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Dopaminergic Neurons Intrinsic to the Primate Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

A femtomolar-acting neuroprotective peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Paracrine and autocrine actions of neurotrophic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Low frequency of alpha-synuclein mutations in familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Differential effects of platelet-derived growth factor isoforms on dopamine neurons in vivo: -BB supports cell survival, -AA enhances fiber formation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Genetic analysis of indefinite division in human cells: evidence for a common immortalizing mechanism in T and B lymphoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Neuroprotective peptide drug delivery and development: potential new therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

The control of firing pattern in nigral dopamine neurons: burst firing

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

The control of firing pattern in nigral dopamine neurons: single spike firing

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Substantia nigra pars reticulata neurons in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Neuroglial networks: neurons and glia talk to each other

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Secretion of GDNF by glial cells does not account for the neurotrophic effect of bFGF on dopamine neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Embryonic stem cells go dopaminergic

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

The next frontier of molecular medicine: delivery of therapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Astrocyte-mediated potentiation of inhibitory synaptic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Neurturin, a relative of glial-cell-line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Astroglia demonstrate regional differences in their ability to maintain primary dendritic outgrowth from mouse cortical neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Separation and identification of peptides from gel-isolated membrane proteins using a microfabricated device for combined capillary electrophoresis/nanoelectrospray mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

S-100 beta and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Target-derived neurotrophic factors regulate the death of developing forebrain neurons after a change in their trophic requirements.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Selective dopamine neurotoxicity by an industrial chemical: an environmental cause of Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Sonic hedgehog facilitates dopamine differentiation in the presence of a mesencephalic glial cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Fibroblast growth factors: Structure-activity on dopamine neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Dissociation of crossed and uncrossed nigrostriatal projections with respect to site of origin in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Glia-derived signals induce synapse formation in neurones of the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Modulation of neuronal activity by glial cells in the retina

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Enhanced survival of cultured dopamine neurons by treatment with soluble extracts from chemically deafferentiated striatum of adult rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Nigral type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

An immortalized, type-1 astrocyte of mesencephalic origin source of a dopaminergic neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Production of dopaminergic neurons for cell therapy in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

P450 enzymes and Parkinson's disease: the story so far.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Modulation of synaptic efficacy and synaptic depression by glial cells at the frog neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

N-acetylcysteine enhances production of dopaminergic neurons from mesencephalic-derived precursor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Dopamine denervation, age of onset, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Calbindin-D28k-containing neurons in the human hypothalamus: relationship to dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Isolation, cloning and characterization of a putative type-1 astrocyte cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Astroglia induce neurogenesis from adult neural stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Standardized methods to bioassay neurotrophic factors for dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrasts with loss in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Control of synapse number by glia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Target-derived BDNF (brain-derived neurotrophic factor) is essential for the survival of developing neurons in the isthmo-optic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Screening of interleukins for survival-promoting effects on cultured mesencephalic dopaminergic neurons from embryonic rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Subpopulations of mesencephalic dopaminergic neurons express different levels of tyrosine hydroxylase messenger RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Neurotrophin small-molecule mimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan. Short communication.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Ciliary neurotrophic factor activates JAK/Stat signal transduction cascade and induces transcriptional expression of glial fibrillary acidic protein in glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

Low dopamine transporter mRNA levels in midbrain regions containing calbindin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2803%2946012-3

7 January 2021

10.1016/S0079-6123(03)46012-3

Identifiers

DOI

1 reference

26 June 2017

1 reference